The inability of the human heart to effectively repair itself after acute ischaemic injury has driven the search for efficacious means of promoting cardiac regenerative growth. Central to this has been the emergence of cell-based strategies to stimulate and augment both myocardial regeneration and neovascularization. Autologous cell transplantation of a variety of adult progenitor cells has been taken forward in clinical trials and, in parallel, investigators have begun to focus on the activation of resident cardiac cell populations as a means to stimulate endogenous repair. The latter approach depends on characterizing native progenitors with self-renewal, clonality, multipotency and arguably an analogous embryological counterpart. Recentl...
Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insuf...
Background—Prolonged myocardial ischemia results in cardiomyocyte loss despite successful revascular...
Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newl...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Efficient cardiac regene ration postinfarction (MI) requires the replacement of lost cardiomyocytes,...
While cardiovascular diseases remain the major worldwide cause of mortality and morbidity, there is ...
Despite recent improvements in interventional medicine, cardiovascular disease still represents the ...
Cardiovascular disease remains the major cause of mortality, and cardiac cell therapy has recently e...
Ischemic heart disease complicated by coronary artery occlusion causes myocardial infarction (MI), w...
Survival rates following myocardial infarction have increased in recent years but current treatments...
The epicardium has, like the other cell lineages of the terminally differentiated adult heart, long ...
A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable s...
Advances in pharmacological and interventional strategies for the treatment of ischaemic heart disea...
Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insuf...
Background—Prolonged myocardial ischemia results in cardiomyocyte loss despite successful revascular...
Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newl...
The inability of the human heart to effectively repair itself after acute ischaemic injury has drive...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Efficient cardiac regeneration postinfarction (MI) requires the replacement of lost cardiomyocytes, ...
Efficient cardiac regene ration postinfarction (MI) requires the replacement of lost cardiomyocytes,...
While cardiovascular diseases remain the major worldwide cause of mortality and morbidity, there is ...
Despite recent improvements in interventional medicine, cardiovascular disease still represents the ...
Cardiovascular disease remains the major cause of mortality, and cardiac cell therapy has recently e...
Ischemic heart disease complicated by coronary artery occlusion causes myocardial infarction (MI), w...
Survival rates following myocardial infarction have increased in recent years but current treatments...
The epicardium has, like the other cell lineages of the terminally differentiated adult heart, long ...
A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable s...
Advances in pharmacological and interventional strategies for the treatment of ischaemic heart disea...
Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insuf...
Background—Prolonged myocardial ischemia results in cardiomyocyte loss despite successful revascular...
Restoring blood flow after myocardial infarction (MI) is essential for survival of existing and newl...